The research behind low-dose use is small: the largest fibromyalgia trial we found, in 99 women, did not show less pain than placebo [8]. Compounded LDN was listed at $15 to $190 by licensed pharmacies in October 2026 [5].
Low dose naltrexone is the off-label use of naltrexone, an opioid blocker approved for alcohol dependence and opioid blockade, at a dose below the labeled 50 mg tablet.
At a glance
Naltrexone is FDA approved as 50 mg tablets for alcohol dependence and opioid blockade; low-dose use is off-label [1] [2].
Approved use vs off-label useThe largest fibromyalgia trial, in 99 women, found no significant pain benefit over placebo [8].
What the research has and has not shownDo not take it with opioids: it blocks opioid pain relief and can bring on sudden withdrawal [1].
Risks and interactions on the FDA labelLicensed compounding pharmacies listed LDN at $15 to $190 in October 2026 [5].
What low dose naltrexone costsLDN needs a prescription and a licensed pharmacy; skip anything sold for research use only.
How people get LDN legally
- Compounded LDN price
- $15 to $190Listed by licensed pharmacies, October 2026 [5]
- Naltrexone on GoodRx
- From $33.30With a GoodRx coupon; $70.19 average retail, Oct 25 2026 [4]
- Biggest risk
- No opioidsIt blocks opioid pain relief and can bring on sudden withdrawal [1]
- Evidence
- Small and mixedThe largest fibromyalgia trial showed no pain benefit over placebo [8]
What low dose naltrexone is
Naltrexone blocks opioid receptors. Its FDA label covers two uses: treating alcohol dependence and blocking the effects of opioids taken from outside the body, and it lists 50 mg once a day as the dose for most patients [1]. "Low dose" means a prescriber orders less than that, for a condition the label does not cover. We do not list low-dose amounts or step-up schedules on this page. Your prescriber and the pharmacy label set those.
FDA calls this off-label use. Its patient guidance says providers generally may prescribe an approved drug for an unapproved use when they judge it medically appropriate, and that FDA has not determined the drug is safe and effective for that use [2].
Approved use vs off-label use
| Use | FDA status | Product | Source |
|---|---|---|---|
| Alcohol dependence | FDA approved | Naltrexone 50 mg tablets | [1] |
| Blocking the effects of opioids | FDA approved | Naltrexone 50 mg tablets | [1] |
| Fibromyalgia, Crohn's disease and other conditions at a low dose | Not approved; off-label | Usually a compounded capsule, tablet or liquid | [1] [2] [5] |
Most LDN is made by compounding pharmacies, which sell it in strengths the approved tablet does not come in [5]. Compounded drugs are not FDA-approved, and FDA does not verify their safety, effectiveness or quality before they are sold [6]. FDA's rules let 503A pharmacies compound with a bulk ingredient that has a USP monograph or is a component of an FDA-approved drug [7], and naltrexone is the active ingredient in approved tablets [1]. So naltrexone can be used as a bulk ingredient under that rule. That does not make compounded LDN an FDA-approved product. For how other compounded products compare, see compounded semaglutide and NAD+ injections.
What the research has and has not shown
Fibromyalgia
A 2025 meta-analysis pooled five randomized trials of LDN against placebo in fibromyalgia. Pain scores were lower on LDN (standardized mean difference -0.61), vivid dreams were more common (risk ratio 2.41), and no serious side effects were reported. The authors said more trials are needed [3].
The largest single trial we found points the other way. In a Danish trial published in The Lancet Rheumatology in December 2023, 99 women with fibromyalgia took LDN or placebo for 12 weeks. Pain fell by 0.34 points more on LDN on an 11-point scale, a difference that was not statistically significant (p=0.27). The authors wrote that the study "did not show that treatment with low-dose naltrexone was superior to placebo in relieving pain" [8].
Crohn's disease
A 2018 Cochrane review found only two small randomized trials with 46 people in all. In the adult trial, remission rates were 30% on LDN and 18% on placebo, a difference that was not statistically significant. Endoscopic response was higher on LDN (72% vs 25%). Cochrane rated the evidence low certainty and said it was not enough "to allow any firm conclusions" [9].
Everything else
LDN is also prescribed for other conditions. We did not review trials for those uses for this page, and we make no claim that LDN treats them. If a prescriber suggests it, ask which trials support your condition and how many people were in them.
Risks and interactions on the FDA label
The label below was written for the 50 mg tablet. Its warnings about opioids apply to the drug itself, so ask your prescriber how they apply at a lower dose.
- Do not take it if you use opioids. The label lists people taking opioid pain medicine, people dependent on opioids and people in opioid withdrawal as contraindicated [1].
- Sudden withdrawal. Naltrexone can bring on opioid withdrawal. The label recommends at least 7 to 10 days free of opioids before starting [1].
- Overdose after stopping. The label reports fatal opioid overdoses in people after they stopped naltrexone [1].
- Opioid medicines may not work. Opioid cough and cold products, opioid antidiarrheals and opioid pain relievers may not help while you take it [1].
- Liver. The label says to stop naltrexone if signs of acute hepatitis appear [1].
- Mood. The label says to watch for depression or suicidal thinking [1].
- Common side effects at 50 mg. Nausea (10%), headache (7%), dizziness, nervousness and fatigue (4% each), insomnia and vomiting (3% each) in the label's alcohol study [1].
- Pregnancy. The label says to use it in pregnancy only if the benefit justifies the risk [1].
Tell every clinician you take naltrexone
In an emergency, opioid pain relief may not work, and the label warns that the higher opioid doses used to override naltrexone can cause deeper and longer breathing problems [1]. Tell the care team you take it. For trouble breathing, severe stomach pain, yellow skin or eyes, or signs of an allergic reaction, call 911.
What low dose naltrexone costs
| Option | Price | What it is | Checked | Source |
|---|---|---|---|---|
| Compounded LDN, licensed pharmacies | $15 to $190 | 85 listed prices for 7 to 90 units; pharmacy names shown only after a quote request | Oct 25 2026 (data as of October 2026) | [5] |
| Compounded LDN, 30 units | $15 to $49.95 in the first 25 listings | Varies by strength, form and pharmacy | Oct 25 2026 | [5] |
| Naltrexone, GoodRx coupon | As low as $33.30 | Most common version on GoodRx; strength and quantity not stated | Oct 25 2026 | [4] |
| Naltrexone, average retail | $70.19 | Without a coupon, most common version | Oct 25 2026 | [4] |
Costs outside the bottle
- The prescriber visit. In-person or telehealth visit fees are separate from the pharmacy price.
- Shipping and refills. Compounded orders may add shipping, and short supplies of 7 or 21 units cost less per order but more per month [5].
- Labs. Ask whether your prescriber wants liver tests, since the label warns about hepatitis [1].
- Insurance. We could not confirm insurance coverage for compounded LDN. Ask your plan and the pharmacy before you fill it.
How people get LDN legally
- A prescriber. LDN needs a prescription. A doctor or other licensed prescriber should review your opioid use, liver health and other medicines first, because those are the label's main warnings [1]. Start with your own doctor. If you pay cash, our guides to functional medicine and concierge medicine explain those practice models.
- A licensed compounding pharmacy. The prescription goes to a state-licensed pharmacy that makes it for you. You can look up any pharmacy with your state board of pharmacy [10]. Our compounding pharmacy guide explains 503A and 503B pharmacies.
- Not a research chemical. Skip any naltrexone sold without a prescription or labeled for research use only. No prescriber or licensed pharmacy stands behind it. Our page on research-use-only drugs explains why.
Naltrexone online
Telehealth prescribers can prescribe naltrexone and LDN where state law allows. We have reviewed two online LDN prescribers that post a price. AgelessRx lists compounded LDN capsules from $25 a month [12], and RTHM gives an example of about $104 per 90 days: a $49 assessment fee plus $55 paid to the pharmacy, before shipping and tax [13]. Superpower also prescribes LDN but did not post a price when we checked [17]. When you compare programs, ask who the prescriber is, which pharmacy fills the order, and whether the visit fee and medicine are priced separately. How we rate companies is on our editorial standards page, and every company we have checked is in our reviews.
We earn commissions from some partners, which can affect where they appear on this page. It never changes a verdict. How we make money
Online LDN prescribers we have reviewed (Clean)
- Clean
Good fit for: low posted prices on LDN, rapamycin and metformin
PriceFrom $25 a month (checked Oct 25 2026) [12]- What you get
- Compounded LDN capsules; monthly, 3-month and 6-month plans [12]
- FDA record
- None found [15]
- BBB
- A+, not accredited [16]
- Note
- Pharmacy not named; serves every state, some treatments limited [18]
Visit AgelessRxon the AgelessRx website
- Clean
Good fit for: LDN for long COVID or ME/CFS with a posted per-request fee
PriceAbout $104 per 90 days: $49 assessment plus $55 pharmacy, before shipping and tax (checked Oct 25 2026) [13]- What you get
- Telehealth for long COVID, ME/CFS and related conditions [13]
- FDA record
- None found [15]
- BBB
- No BBB profile found
- Note
- 14 states; names Infuserve America for compounded orders [14]
Visit RTHMon the RTHM website
Questions to ask before you start
- Which trials support LDN for my condition, and how large were they?
- What other medicines am I taking that contain an opioid, including cough syrup or antidiarrheals [1]?
- Which pharmacy will make it, and is it state licensed [10]?
- What will I pay each month for the visit and the medicine together?
Naltrexone also appears on our PT-141 page, whose label says to avoid using it with oral naltrexone products taken for alcohol or opioid addiction, because it may sharply lower naltrexone levels [11].
Questions people ask
What is low dose naltrexone?
Is low dose naltrexone FDA approved?
What is low dose naltrexone used for?
Does low dose naltrexone work for fibromyalgia?
How much does low dose naltrexone cost?
Can I get naltrexone online?
Yes, with a prescription from a telehealth prescriber where state law allows, filled by a licensed pharmacy you can look up with your state board [10]. We have not reviewed an online LDN seller, so we do not link to one.
Can I take low dose naltrexone with opioids?
The naltrexone label lists people taking opioid pain medicine or dependent on opioids as contraindicated, and it can bring on sudden withdrawal. It recommends 7 to 10 days free of opioids before starting [1].
Medical review: pending. A licensed clinician has not yet reviewed this page.
Sources
18 cited
- Naltrexone hydrochloride tablets USP 50 mg, prescribing information (A-S Medication Solutions). US Food and Drug Administration, FDALabel, 2023-12-15 (accessed 2026-10-25).
- Understanding unapproved use of approved drugs "off label". US Food and Drug Administration, 2018-02-05 (accessed 2026-10-25).
- Efficacy and safety of low-dose naltrexone (LDN) in fibromyalgia: a systematic review and meta-analysis (Nazir et al., Annals of Medicine and Surgery). PubMed, Mar 28, 2025.
- Naltrexone prices. GoodRx, accessed 2026-10-25.
- Low-dose naltrexone (LDN) price comparison. CompoundingFinder, October 2026 (accessed 2026-10-25).
- Compounding and the FDA: questions and answers. US Food and Drug Administration, 2025-09-16 (accessed 2026-10-25).
- Bulk drug substances used in compounding under section 503A of the FD&C Act. US Food and Drug Administration, 2026-05-14 (accessed 2026-10-25).
- Low-dose naltrexone versus placebo in women with fibromyalgia: a randomized, double-blind trial (Bruun et al., The Lancet Rheumatology). Odense University Hospital (author copy), Dec 5, 2023.
- Low dose naltrexone for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews, Apr 2018.
- Boards of pharmacy. National Association of Boards of Pharmacy, accessed 2026-10-25.
- Vyleesi (bremelanotide) prescribing information. US Food and Drug Administration, FDALabel, 2025-01-10 (accessed 2026-10-25).
- Low Dose Naltrexone (LDN). AgelessRx, modified 2026-10-16 (accessed 2026-10-25).
- Low dose naltrexone. RTHM, Oct 25, 2026.
- RTHM support and FAQ. RTHM, Oct 25, 2026.
- Warning letters database. U.S. Food and Drug Administration, Oct 25, 2026.
- AgelessRx, Inc. BBB business profile. Better Business Bureau, Oct 25, 2026.
- Low dose naltrexone. Superpower, Oct 25, 2026.
- AgelessRx frequently asked questions. AgelessRx, Oct 25, 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.